Review Note
Last Update: 03/15/2024 10:45 AM
Current Deck: Collab4PG
Published
Fields:
Text
In PAH patients who have a positive vasoreactivity test, {{c1::calcium channel blockers}} are indicated for first-line treatment.
Extra
eg. sustained-release nifedipine, amlodipine or diltiazem
Vasoreactivity testing involves the administration of inhaled nitric oxide, IV epoprostenol, IV adenosine, or inhaled iloprost.
The test is considered positive if the mean pulmonary arterial pressure (mPAP) decreases by at least 10 mmHg and to a final value ≤ 40 mmHg, without a decrease in cardiac output.
Vasoreactivity testing involves the administration of inhaled nitric oxide, IV epoprostenol, IV adenosine, or inhaled iloprost.
The test is considered positive if the mean pulmonary arterial pressure (mPAP) decreases by at least 10 mmHg and to a final value ≤ 40 mmHg, without a decrease in cardiac output.
Lecture Notes
Missed Questions
Pathoma
Boards and Beyond
First Aid
Sketchy
Sketchy 2
Sketchy Extra
Picmonic
Pixorize
Physeo
Bootcamp
Additional Resources
One by one
Tags:
Suggested Changes:
Deck Changes (Suggestion to move the Note to the following Deck):
Field Changes:
Tag Changes: